Sector
PharmaceuticalsOpen
₹1,213.1Prev. Close
₹1,172.1Turnover(Lac.)
₹3.45Day's High
₹1,213.1Day's Low
₹1,15052 Week's High
₹1,749.6552 Week's Low
₹814.1Book Value
₹653.59Face Value
₹10Mkt Cap (₹ Cr.)
355.36P/E
16.88EPS
70.69Divi. Yield
0.1327 May 2024
12:00 AM
Dividend
Dividend Amount: 1.5
Record Date: 23 Sep, 2024
9 Aug 2024
12:00 AM
AGM
Announcement Date: 09 Aug, 2024
22 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 3.02 | 3.02 | 3.02 | 3.02 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 173.2 | 161 | 148.19 | 123.31 |
Net Worth | 176.22 | 164.02 | 151.21 | 126.33 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 260.25 | 256.92 | 344.15 | 212.98 |
yoy growth (%) | 1.29 | -25.34 | 61.58 | -1.34 |
Raw materials | -139.65 | -162.04 | -230.28 | -132.95 |
As % of sales | 53.66 | 63.07 | 66.91 | 62.42 |
Employee costs | -27.11 | -23.27 | -20.63 | -17.64 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 19.35 | 13.33 | 23.75 | 6.39 |
Depreciation | -7.21 | -7.24 | -5.76 | -5.7 |
Tax paid | -6.18 | -4.19 | -7.12 | 0.1 |
Working capital | 6.74 | 5.62 | 4.3 | 1.01 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 1.29 | -25.34 | 61.58 | -1.34 |
Op profit growth | 25 | -26.72 | 145.88 | -53.6 |
EBIT growth | 29.45 | -36.93 | 176.29 | -57.05 |
Net profit growth | 43.95 | -45 | 155.84 | -49.77 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 344.72 | 305.96 | 315.56 | 349.74 | 265.59 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 344.72 | 305.96 | 315.56 | 349.74 | 265.59 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 4.86 | 3.83 | 5.42 | 14.76 | 1.78 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,677.5 | 94 | 4,02,584.41 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,859.5 | 82.46 | 1,82,147.28 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,497.6 | 25.13 | 1,20,934.05 | 1,485.4 | 1.07 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,349.4 | 59.47 | 1,13,319.98 | 474 | 0.96 | 2,385 | 224.33 |
Dr Reddys Laboratories Ltd DRREDDY | 1,270.8 | 19.84 | 1,06,137.94 | 1,200.7 | 0.63 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
T V V S N Murthy
Independent Director
P Sarath Kumar
Company Sec. & Compli. Officer
Trupti Ranjan Mohanty
Executive Director
Talluri Venkata Praveen
Whole-time Director
Sudeepthi Gopineedi
Independent Director
Mannam Malakondaiah
Independent Director
Srinivas Samavedam
Independent Director
Sundaramma Patibandla
Plot No 19-III Road No 71,
Opp Bharatiya Vidya Bhavan PSc,
Telangana - 500096
Tel: 91-040-6628-8888
Website: http://www.smslife.in
Email: info@smslife.in
1-2-285 Domalguda,
Hyderabad - 500 029
Tel: 91-040-27638111/4445
Website: www.aarthiconsultants.com
Email: info@aarthiconsultants.com
Summary
SMS Lifesciences India Limited was incorporated originally as Potluri Real Estate Private Limited on May 31, 2006. The Companys name was changed to Potluri Packaging Industries Private Limited on 6 No...
Read More
Reports by SMS Lifesciences India Ltd
What is the SMS Lifesciences India Ltd share price today?
What is the Market Cap of SMS Lifesciences India Ltd?
What is the PE and PB ratio of SMS Lifesciences India Ltd?
What is the 52 Week High and Low of SMS Lifesciences India Ltd?
What is the CAGR of SMS Lifesciences India Ltd?
What is the shareholding pattern of SMS Lifesciences India Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.